Ferguson, R <br/><br/>
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Jan 2011 
 - 66-76 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-6143.2010.03338.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Adrenal Cortex Hormones--adverse effects<br/>Adult<br/>Calcineurin Inhibitors<br/>Female<br/>Graft Rejection<br/>Graft Survival--drug effects<br/>Humans<br/>Immunoconjugates--adverse effects<br/>Immunosuppression Therapy--adverse effects<br/>Kidney--physiology<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Sirolimus--therapeutic use<br/>Tacrolimus--therapeutic use